Loading publications…
The last 5 uploaded publications
ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban
Marc Schindewolf, Bernd Brüggenjürgen, Cihan Ay, Pierre Hainaut, Ulrike Hoffmann, Seán Gaine, Michiel Coppens, Daniela Jimenez-Harrison, Patrick Lévy, Julio López Bastida, Éric Vicaut, Peter Bramlage, Giancarlo Agnelli, A. Cohen (2020). ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban.
Article76 days agoAssociation between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolledin the Edoxaban Treatment in routine cliNical prActice for patients with acute VTE in Europe (ETNA-VTE-Europe) registry
Michiel Coppens, Alexander T. Cohen, Cihan Ay, Pierre Hainaut, Ulrich Hoffmann, Seán Gaine, David Jiménez, Marc Schindewolf, Bernd Brüggenjürgen, Pierre Lévy, Julio López Bastida, Éric Vicaut, Peter Bramlage, Giancarlo Agnelli (2020). Association between index venous thromboembolism (VTE) event and 12-months outcomes for patients in routine clinical practice enrolledin the Edoxaban Treatment in routine cliNical prActice for patients with acute VTE in Europe (ETNA-VTE-Europe) registry. , DOI: https://doi.org/10.7892/boris.144861.
Article76 days agoCorrection to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
Alexander T. Cohen, Cihan Ay, Pierre Hainaut, Hervé Decousus, Ulrich Hoffmann, Seán Gaine, Michiel Coppens, Pedro Silva Cunha, David Jiménez, Beatrice Amann‐Vesti, Bernd Brüggenjürgen, Pierre Lévy, Julio López Bastida, Éric Vicaut, Petra Laeis, Eva‐Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Peter Bramlage, Giancarlo Agnelli (2018). Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study. , 16(1), DOI: https://doi.org/10.1186/s12959-018-0173-5.
Article76 days agoPredictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)
Nicole M. Kuderer, Marek S. Poniewierski, Eva Culakova, Gary H. Lyman, Alok A. Khorana, Ingrid Pabinger, Giancarlo Agnelli, Howard A. Liebman, Éric Vicaut, Guy Meyer, Frances A. Shepherd (2017). Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK). , 23(2), DOI: https://doi.org/10.1634/theoncologist.2017-0205.
Article76 days agoFibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Guy Meyer, Éric Vicaut, Thierry Danays, Giancarlo Agnelli, Cecilia Becattini, Jan Beyer‐Westendorf, Erich Bluhmki, Hélène Bouvaist, Benjamin Brenner, Françis Couturaud, Claudia Dellas, Klaus Empen, Ana Paula Figueiredo de Montalvão França, Nazzareno Galiè, Annette Geibel, Samuel Z. Goldhaber, David Jiménez, Matija Kozak, Christian Kupatt, Nils Kucher, Iréne Lang, Mareike Lankeit, Nicolas Méneveau, G Pacouret, Massimiliano Palazzini, Antoniu Octavian Petriș, Piotr Pruszczyk, Matteo Rugolotto, Aldo Salvi, Sebastian Schellong, Mustapha Sebbane, Bożena Sobkowicz, Branislav Stefanović, Hölger Thiele, Adam Torbicki, Franck Verschuren, Stavros Konstantinides (2014). Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism. , 370(15), DOI: https://doi.org/10.1056/nejmoa1302097.
Article76 days ago